Eli Lilly stops trial of antibody drug over safety concern

IMANA Webinar: Covid-19 Updates by Dr. Uzma Syed, Dr. Asma Moheet (October 2020)Подробнее

COVID-19 antibody treatment clinical trial paused over potential safety concernПодробнее

Bill Gates on Eli Lilly pausing antibody trial due to safety concernsПодробнее

Coronavirus research: Johnson and Johnson and Eli Lilly pause trials amid safety concernsПодробнее

Eli Lilly’s Coronavirus Antibody Treatment Trial Halted | NBC Nightly NewsПодробнее

Eli Lilly antibody treatment study paused due to safety concernsПодробнее

Citing Safety Reasons, Eli Lilly Halts COVID Treatment TrialПодробнее

Eli Lilly pauses coronavirus antibody treatmentПодробнее

Eli Lilly confirms it has paused one of its Covid-19 antibody testsПодробнее

Eli Lilly Covid Antibody Drug Gets Emergency FDA ClearanceПодробнее

Eli Lilly pausing Covid-19 trials is not a big deal: Jefferies managing directorПодробнее

Coronavirus treatment trials halted over safety concernsПодробнее

Eli Lilly releases new data from potentially game-changing weight loss drug trialПодробнее

Antibody drugs from Regeneron, Eli Lilly should no longer be used, FDA saysПодробнее

Eli Lilly CEO explains supply chain of Covid-19 antibody drugПодробнее

Eli Lilly reports results from Covid-19 phase 2 antibody drug trialПодробнее

Eli Lilly CEO on Covid antibody treatment's effectiveness against mutationsПодробнее

Eli Lilly starts late-stage trial for Covid-19 antibody drug in nursing homesПодробнее

Eli Lilly CEO discusses its coronavirus antibody drug and the latest on its breast cancer treatmentПодробнее

Eli Lilly reports positive phase 3 trial results for Covid antibody drugПодробнее